Development of an integrated platform for the use of adult human primary cardiomyocytes in preclinical safety assessment
Ended Project Grant Awarded Last action
- Award ID
- R44TR003162
- Recipient
-
Anabios Corp UEI P3N4G7B5SRA7
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,132,289
Award facts
- Assistance listing
- 93.350 National Center for Advancing Translational Sciences
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $1,132,289 |
Quick answers
Who received award R44TR003162?
R44TR003162 was awarded to Anabios Corp by National Center for Advancing Translational Sciences (National Institutes of Health) on March 4, 2020.
How much is award R44TR003162 worth?
$1,132,289 has been obligated on R44TR003162.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award